Recon: FTC reports says PBMs seek profits to detriment of patients and pharmacies; Pfizer’s chief scientist to step down
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States